Event Type
Disclosure
Mandatory
Variant
8-K
Results of Operations and Financial Condition. On February 23, 2026, BioMarin Pharmaceutical Inc. (the Company) announced financial results for its fourth quart
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release of the Company dated February 23, 2026 104 Cover Page Interactive